Intravenous Immunoglobulin Therapy for Pyoderma Gangrenosum: A Multicenter Retrospective Analysis in 81 Patients: Intravenous Immunoglobulin Therapy for Pyoderma Gangrenosum: A Multicenter Retrospective Analysis: M. Ronicke et al.

Background: Pyoderma gangrenosum (PG) is rare neutrophil skin disease causing painful, progressively enlarging ulcers. Among the treatment options, intravenous immunoglobulin (IVIG) is a therapy of first choice for paraneoplastic PG. Otherwise, it is used in therapy-refractory courses. Objective: To...

Full description

Bibliographic Details

Published in:	American Journal of Clinical Dermatology Vol. 26; no. 1; pp. 139 - 147
Main Authors:	Ronicke, Moritz, Sollfrank, Lukas, Vitus, Martin V., Walter, Lukas J., Krieter, Manuel, Moelleken, Maurice, Dissemond, Joachim, Schultz, Erwin, Lauffer, Felix, von den Driesch, Peter, Erfurt-Berge, Cornelia
Format:	research tables/charts Journal Article
Published:	Springer Nature Jan2025
Online Access:	View this record in EBSCOhost